Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06975046 · ClinicalTrials.gov registry record · NA
Aerodynamic Measurements in the Pediatric Population
A NA study of Normal Voice, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 365
- Enrollment target
- 2
- Study locations
NCT06975046: Recruiting NA study of Normal Voice, sponsored by University of Wisconsin, Madison.
NCT06975046 is a NA study of Normal Voice that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 365 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06975046, a NA study of Normal Voice, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 365 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to create a vocal health database of people aged 4-17 with no diagnosed voice pathology. The main question it aims to answer is: * what is the best way to assess pediatric voices; and, * what are the differences between healthy and dysphonic pediatric voices? Participants will complete one 60 minute session involving one of three types of aerodynamic interruption.
Primary Outcome
Subglottic pressure is measured in kPa of leakage of air between the vocal folds and the resistance to that flow during speech
Conditions Studied
Interventions
- DEVICE Complete airflow interruption
- DEVICE Incomplete airflow interruption
- DEVICE Airflow redirection
Study Locations (2)
Iowa
- University of Iowa - Iowa City
Wisconsin
- University of Wisconsin - Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2025-12-22 |
| Est. Completion | 2030-12 |
| Phase | NA |
What NCT06975046 shows while recruiting
NCT06975046 is an interventional study that assigns participants to a tested intervention. The registered 365 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Normal Voice appearing as the primary indexed condition, and to 3 interventions - of which Complete airflow interruption is the first listed.
NCT06975046 reports a single indexed study location in Iowa, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06975046 about?
NCT06975046 is a clinical study titled "Aerodynamic Measurements in the Pediatric Population". The goal of this clinical trial is to create a vocal health database of people aged 4-17 with no diagnosed voice pathology. The main question it aims to answer is: * what is the best way to assess pediatric voices; and, * what are the differences between healthy and dysphonic pediatric voices? Par...
What is the current status of trial NCT06975046?
This trial is currently recruiting. It is a NA study. The enrollment target is 365 participants. The study started on 2025-12-22. Estimated completion is 2030-12.
What conditions does trial NCT06975046 study?
This clinical trial studies the following conditions: Normal Voice.
What interventions are being tested in trial NCT06975046?
The interventions under investigation include: Complete airflow interruption (DEVICE), Incomplete airflow interruption (DEVICE), Airflow redirection (DEVICE).
Who is sponsoring clinical trial NCT06975046?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06975046 being conducted?
This trial has 2 study locations across Iowa, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06975046's enrollment target sits among peer trials
365 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04049604 · 365 participants · NA
IDENTIFY Study: Natural History of Maternal Neoplasia
- NCT05065840 · 365 participants · NA
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
- NCT05303519 · 365 participants · Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NCT05592626 · 365 participants · Phase 1
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI